Wockhardt Life Sciences has hived off its IV fluids business to Baxter India, Indian arm of the $7-billion US healthcare major, Baxter Healthcare International, for Rs 195 crore ($40 million). This is part of Wockhardt
Wockhardt Sells Iv Fluids Business To Baxter India
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 07 2002 | 12:00 AM IST
